Medicament for treating primary bronchogenic carcinoma

Medicament for treating primary bronchogenic carcinoma

  • CN 103,169,929 A
  • Filed: 03/31/2013
  • Published: 06/26/2013
  • Est. Priority Date: 03/31/2013
  • Status: Active Application
First Claim
Patent Images

1. medicine of be used for curing primary bronchogenic carcinoma of lung, set medical its compositing formula of compound pulmonary carcinoma capsule preparations of development small lot medicine by:

  • Radix Ginseng 20g, Radix Astragali 30g, Herba Hedyotidis Diffusae 30g, Radix Ranunculi Ternati 20g, Stigma Croci 3g, Typhonium flagelliforme (Lodd.) Blume powder 6g, Moschus 0.15g, Herba Lobeliae Chinensis 15g, Rhizoma Curcumae 15g, Flos Campsis 10g, Rhizoma Cyperi 10g, Semen Persicae 10g, Fructus Akebiae 10g, Gekko Swinhonis 30g, Cordyceps 20g, Ganoderma spore powder with cellular wall broken 30g, Chinese crude drug and packaging material form;

    The Chinese medicine of preparing burden in right amount, select materials through the tunnel, the conventional process of preparing Chinese medicine, low baking temperature oven dry roasting is dry, dress up a kind of standby preparation of medicine of curing primary bronchogenic carcinoma of lung of 1 packed traditional Chinese medicinal material raw materials of parcel, after getting above-mentioned 1 standby preparation of the packed traditional Chinese medicinal material raw materials of parcel during preparation and being broken into the 120 thin medicamental pulverata of order with small-sized electric pulverizer processing powder, then after adopting Capsules to fill thin medicamental pulverata, processing makes capsule preparations;

    Every capsules weight is 0.3 gram/grain or 0.5 gram/grain, is distributed into 100/bottle, and room temperature saves backup.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×